Blood test could speed up cancer treatment decisions, study hopes
NCT ID NCT07096362
Summary
This study is testing whether a simple blood test can tell doctors if chemotherapy is working for metastatic pancreatic cancer faster than the current standard of waiting 8 weeks for scans. Researchers will measure tumor DNA in the blood of 50 participants at different time points to see if changes predict treatment response. The goal is to help doctors make treatment decisions sooner, potentially switching to a different therapy earlier if the current one isn't working.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Miami
RECRUITINGMiami, Florida, 33136, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.